|
Volumn 115, Issue 2, 1986, Pages 211-216
|
Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin)
a b c a b c |
Author keywords
[No Author keywords available]
|
Indexed keywords
AURANOFIN;
GLUCOCORTICOID;
GOLD DERIVATIVE;
HYDROXYCHLOROQUINE;
PREDNISOLONE;
ADVERSE DRUG REACTION;
ALKALINE PHOSPHATASE BLOOD LEVEL;
APHTHOUS STOMATITIS;
CLINICAL ARTICLE;
DIARRHEA;
DISCOID LUPUS ERYTHEMATOSUS;
DRUG EFFICACY;
DRUG THERAPY;
ERYTHEMA;
GASTROINTESTINAL TOXICITY;
HUMAN;
INTOXICATION;
KIDNEY;
LIVER TOXICITY;
MOUTH;
NAUSEA;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PROTEINURIA;
PRURITUS;
RASH;
SKIN TOXICITY;
THERAPY;
VOMITING;
ADOLESCENT;
ADULT;
AGED;
AURANOFIN;
AUROTHIOGLUCOSE;
CHRONIC DISEASE;
CLINICAL TRIALS;
FEMALE;
GOLD;
HUMANS;
LUPUS ERYTHEMATOSUS, DISCOID;
MALE;
MIDDLE AGED;
|
EID: 0022444882
PISSN: 00070963
EISSN: 13652133
Source Type: Journal
DOI: 10.1111/j.1365-2133.1986.tb05720.x Document Type: Article |
Times cited : (69)
|
References (6)
|